Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Microbe–microbe interactions during Clostridioides difficile infection
A Abbas, JP Zackular - Current opinion in microbiology, 2020 - Elsevier
Clostridioides difficile is the leading cause of hospital-acquired gastrointestinal infections
and a major public health burden in the United States. C. difficile infection causes a …
and a major public health burden in the United States. C. difficile infection causes a …
Bacteria engineered to treat metabolic diseases
D Falb, VM Isabella, JW Kotula, PF Miller… - US Patent …, 2022 - Google Patents
2018-04-05 Assigned to SYNLOGIC, INC. reassignment SYNLOGIC, INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISHER, ADAM …
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISHER, ADAM …
RETRACTED: Clostridium scindens Is Present in the Gut Microbiota during Clostridium difficile Infection: a Metagenomic and Culturomic Analysis
S Amrane, D Bachar, JC Lagier… - Journal of clinical …, 2018 - journals.asm.org
Clostridium scindens was first isolated in 1984 during work on the gut microbiota's steroid
production (1). It became of great interest in 2015 with the study proposed by Buffie et al.(2) …
production (1). It became of great interest in 2015 with the study proposed by Buffie et al.(2) …
Compositions and methods for treating antibiotic resistance
US12214002B2 - Compositions and methods for treating antibiotic resistance - Google
Patents US12214002B2 - Compositions and methods for treating antibiotic resistance …
Patents US12214002B2 - Compositions and methods for treating antibiotic resistance …
Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof
The present disclosure relates to novel lantibiotics, lantibi otic pharmaceutical compositions,
isolated and recombinant lantibiotic-producing bacteria, bacterial pharmaceutical …
isolated and recombinant lantibiotic-producing bacteria, bacterial pharmaceutical …
Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof
G McKenzie, MJL McKenzie, DN Cook, M Vulic… - US Patent …, 2023 - Google Patents
2023-03-16 Assigned to Seres Health, Inc. reassignment Seres Health, Inc. ASSIGNMENT
OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOODMAN …
OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOODMAN …
Compositions and methods for modifying bile acids to regulate lipid and steroid metabolism
WO2023114180A1 - Compositions and methods for modifying bile acids to regulate lipid and
steroid metabolism - Google Patents WO2023114180A1 - Compositions and methods for modifying …
steroid metabolism - Google Patents WO2023114180A1 - Compositions and methods for modifying …
Microbial compositions and methods of use for canine enteropathy and dysbiosis
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O [C@ H] 1 [C@
H](O)[C@@ H](CO) O [C@@] 1 (CO) OC [C@] 1 (OC [C@] 2 (OC [C@] 3 (OC [C@] 4 (OC …
H](O)[C@@ H](CO) O [C@@] 1 (CO) OC [C@] 1 (OC [C@] 2 (OC [C@] 3 (OC [C@] 4 (OC …
Bacteria engineered to treat metabolic diseases
D Falb, VM Isabella, JW Kotula, PF Miller… - US Patent …, 2024 - Google Patents
2022-01-30 Assigned to SYNLOGIC, INC. reassignment SYNLOGIC, INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISHER, ADAM …
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISHER, ADAM …
Defined therapeutic microbiota and methods of use thereof
2020-07-07 Assigned to THE BRIGHAM AND WOMEN'S HOSPITAL, INC. reassignment
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ASSIGNMENT OF ASSIGNORS …